Treatment of PTEN-mutant tumor xenografts by intratumor (i.t.)injection of PIK3CB siRNA (siPIK3CB) or by expression of doxycycline (doxy)-inducible PIK3CB shRNA was markedly more potent than PI3Kβ inhibition. The gene discussed is PTEN; the disease is neoplasm.